Yichang Ren

870 total citations
25 papers, 718 citations indexed

About

Yichang Ren is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yichang Ren has authored 25 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Yichang Ren's work include Cancer Immunotherapy and Biomarkers (7 papers), Peptidase Inhibition and Analysis (7 papers) and Synthesis and biological activity (6 papers). Yichang Ren is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Peptidase Inhibition and Analysis (7 papers) and Synthesis and biological activity (6 papers). Yichang Ren collaborates with scholars based in China and United States. Yichang Ren's co-authors include Jianjun Chen, Binbin Cheng, Hao Cao, Gang Li, Jin Liu, Yuxi Wang, Xiaopeng Peng, Shuwen Liu, Wei Wang and Lingling Ma and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Yichang Ren

23 papers receiving 709 citations

Peers

Countries citing papers authored by Yichang Ren

Since Specialization

Citations

This map shows the geographic impact of Yichang Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichang Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichang Ren more than expected).

Fields of papers citing papers by Yichang Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichang Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichang Ren. The network helps show where Yichang Ren may publish in the future.

Co-authorship network of co-authors of Yichang Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yichang Ren. A scholar is included among the top collaborators of Yichang Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichang Ren. Yichang Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases 2025 ·Journal of Medicinal Chemistry ·Yuqi Fan, Rui Ma, (unknown), (unknown), Yichang Ren, (unknown), Chen‐Yu Zhang, Feifei Liu, Zhongping Jiang, Yong Rao, Congjun Xu, Ling Huang, Jianjun Chen, Jin Liu	0
2	Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment 2025 ·Journal of Medicinal Chemistry ·Zichao Yang, Yang Pan, Jian-Wei Xu, (unknown), Jiayi Zhou, Haiqi He, (unknown), Yichang Ren, Meirong Chen, Yibei Xiao, Jianjun Chen	1
3	Discovery of novel resorcinol biphenyl ether-based macrocyclic small molecules as PD-1/PD-L1 inhibitors with favorable pharmacokinetics for cancer immunotherapy 2023 ·Bioorganic Chemistry ·Zichao Yang, Ziqing Liu, (unknown), Jian-Wei Xu, Ting Liu, Haiqi He, Ling Li, Yichang Ren, Jianjun Chen	8
4	Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents 2023 ·Journal of Medicinal Chemistry ·Jin Liu, Yao Cheng, L. Yuan, Ting Liu, (unknown), Yichang Ren, Ling Li, Sheng Jiang, Yibei Xiao, Jianjun Chen	19
5	Design, synthesis, and bioevaluation of imidazo [1,2–a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities 2022 ·Bioorganic & Medicinal Chemistry ·(unknown), Zhiqiang Sun, Yuxi Wang, (unknown), Zichao Yang, Yichang Ren, Jin Liu, Junli Huang, (unknown), Ting Chen, Canjun Zeng, Jianjun Chen	8
6	Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma 2022 ·Journal of Medicinal Chemistry ·Xiaopeng Peng, Ling Li, Jingxuan Chen, (unknown), Yichang Ren, Jin Liu, Ziwen Yu, Hao Cao, Jianjun Chen	35
7	Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects 2022 ·Journal of Medicinal Chemistry ·Xiaopeng Peng, Yichang Ren, (unknown), Jin Liu, Jianjun Chen	16
8	Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screening 2022 ·European Journal of Medicinal Chemistry ·Ling Li, Jin Liu, Zichao Yang, (unknown), (unknown), Yichang Ren, (unknown), Junli Huang, Jianjun Chen	26
9	Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities 2021 ·Bioorganic & Medicinal Chemistry ·Yichang Ren, (unknown), Binbin Cheng, Ling Li, Jin Liu, (unknown), Jianjun Chen	23
10	Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents 2021 ·Journal of Medicinal Chemistry ·Xiaopeng Peng, Jingxuan Chen, Ling Li, Zhiqiang Sun, Jin Liu, Yichang Ren, Junli Huang, Jianjun Chen	44
11	Design, synthesis and biological evaluation of benz‐fused five‐membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities 2021 ·Chemical Biology & Drug Design ·(unknown), Yichang Ren, Mingming Xue, Binbin Cheng, Jin Liu, Yao Liu, Jianjun Chen	8
12	Synthesis and pharmacological evaluation of a novel synthetic peptide CWHTH based on the Styela clava-derived natural peptide LWHTH with improved antioxidant, hepatoprotective and angiotensin converting enzyme inhibitory activities 2021 ·International Journal of Pharmaceutics ·Xin Deng, (unknown), Chen‐Yu Zhang, Jiaqi Liu, Yichang Ren, Gang Li, Jianjun Chen	8
13	Three new steroidal sapogenins derived from the roots of Cynanchum otophyllum and their cytotoxic activities 2021 ·Phytochemistry Letters ·(unknown), Xuemei Yang, Li Liu, Meng Zhang, Yichang Ren, (unknown), Rui Xing, (unknown), (unknown), Jinshan Tang	4
14	Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities 2021 ·Journal of Medicinal Chemistry ·Yichang Ren, Yuxi Wang, Gang Li, (unknown), Lingling Ma, Binbin Cheng, Jianjun Chen	87
15	Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents 2020 ·Journal of Medicinal Chemistry ·Binbin Cheng, Yichang Ren, Xiaoge Niu, Wei Wang, Shuanghu Wang, Yingfeng Tu, Shuwen Liu, Jin Wang, (unknown), Guochao Liao, Jianjun Chen	66
16	Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment 2020 ·Journal of Medicinal Chemistry ·Binbin Cheng, Wei Wang, Xiaoge Niu, Yichang Ren, Ting Liu, Hao Cao, Shuanghu Wang, Yingfeng Tu, Jingxuan Chen, Shuwen Liu, (unknown), Jianjun Chen	43
17	Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities 2020 ·European Journal of Medicinal Chemistry ·Gang Li, Yuxi Wang, Ling Li, Yichang Ren, Xin Deng, Jin Liu, Wei Wang, Meihua Luo, Shuwen Liu, Jianjun Chen	43
18	Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1 2020 ·European Journal of Medicinal Chemistry ·Binbin Cheng, Yichang Ren, Hao Cao, Jianjun Chen	87
19	Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment 2020 ·European Journal of Medicinal Chemistry ·Xin Deng, (unknown), Chen‐Yu Zhang, (unknown), Yichang Ren, Gang Li, Binbin Cheng, Ling Li, Zhiqiang Yu, Jianjun Chen	51
20	Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy 2018 ·Biochemical and Biophysical Research Communications ·Xinran Geng, Yichang Ren, Fangfang Wang, Danmei Tian, Xin‐Sheng Yao, Youwei Zhang, Jinshan Tang	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact